These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33231168)

  • 1. Successful treatment of drug-resistant cataplexy with the anticholinergic drug tropatepine.
    Nigam M; Leu-Semenescu S; Arnulf I
    J Clin Sleep Med; 2021 Apr; 17(4):849-851. PubMed ID: 33231168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study.
    Lecendreux M; Poli F; Oudiette D; Benazzouz F; Donjacour CE; Franceschini C; Finotti E; Pizza F; Bruni O; Plazzi G
    Sleep; 2012 May; 35(5):709-11. PubMed ID: 22547897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cataplexy.
    Reading P
    Pract Neurol; 2019 Feb; 19(1):21-27. PubMed ID: 30355740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating pitolisant as a narcolepsy treatment option.
    de Biase S; Pellitteri G; Gigli GL; Valente M
    Expert Opin Pharmacother; 2021 Feb; 22(2):155-162. PubMed ID: 32941089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.
    Thorpy MJ; Bogan RK
    Sleep Med; 2020 Apr; 68():97-109. PubMed ID: 32032921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness.
    Inocente C; Arnulf I; Bastuji H; Thibault-Stoll A; Raoux A; Reimão R; Lin JS; Franco P
    Clin Neuropharmacol; 2012; 35(2):55-60. PubMed ID: 22356925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy.
    Parmar A; Murray BJ; Narang I
    Curr Neurol Neurosci Rep; 2020 Jul; 20(9):38. PubMed ID: 32651734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.
    Szabo ST; Thorpy MJ; Mayer G; Peever JH; Kilduff TS
    Sleep Med Rev; 2019 Feb; 43():23-36. PubMed ID: 30503715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
    Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple treatment comparison in narcolepsy: a network meta-analysis.
    Lehert P; Falissard B
    Sleep; 2018 Dec; 41(12):. PubMed ID: 30239930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.
    Murali H; Kotagal S
    Sleep; 2006 Aug; 29(8):1025-9. PubMed ID: 16944670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U; Bassetti CL
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Excessive Daytime Sleepiness in Narcolepsy With Baclofen.
    Morse AM; Kelly-Pieper K; Kothare SV
    Pediatr Neurol; 2019 Apr; 93():39-42. PubMed ID: 30595352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
    Junnarkar G; Allphin C; Profant J; Steininger TL; Chen C; Zomorodi K; Skowronski R; Black J
    Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for narcolepsy.
    Abad VC; Guilleminault C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.